SCHEMBL1209718

SCHEMBL1209718

N#Cc1c(NC(=O)C=Cc2ccoc2)sc2c1CCC(OC(=O)N1CC(O)C1)C2

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TGFBR1 P36897 3/20 0.45
ALDH1A1 P00352 11/20 0.44
RAB9A P51151 6/20 0.44
POLB P06746 5/20 0.44
NPC1 O15118 5/20 0.44
KMT2A Q03164 5/20 0.44
MEN1 O00255 4/20 0.44
KDM4E B2RXH2 4/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
LMNA P02545 2/20 0.44
MAPT P10636 2/20 0.44
HPGD P15428 1/20 0.44
NR0B1 P51843 1/20 0.44
PTPN5 P54829 1/20 0.42
ALOX15 P16050 1/20 0.37
MAPK1 P28482 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
GAA P10253 1/20 0.36
TNF P01375 1/20 0.36
NOD1 Q9Y239 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1210121 0.95 TGFBR1 (0.44) TGFBR1ALDH1A1RAB9APOLBNPC1
SCHEMBL1209151 0.93 TGFBR1 (0.44) TGFBR1ALDH1A1RAB9APOLBNPC1
SCHEMBL1210014 0.93 TGFBR1 (0.45) TGFBR1ALDH1A1RAB9APOLBNPC1
SCHEMBL1207428 0.93 TGFBR1 (0.45) TGFBR1ALDH1A1RAB9APOLBNPC1
SCHEMBL1208266 0.92 ALDH1A1 (0.44) TGFBR1ALDH1A1RAB9APOLBNPC1
SCHEMBL1209136 0.91 TGFBR1 (0.48) TGFBR1ALDH1A1RAB9APOLBNPC1
SCHEMBL1209165 0.91 TGFBR1 (0.48) TGFBR1ALDH1A1RAB9APOLBNPC1
SCHEMBL1210683 0.91 TGFBR1 (0.46) TGFBR1ALDH1A1RAB9APOLBNPC1
SCHEMBL1210197 0.91 TGFBR1 (0.47) TGFBR1ALDH1A1RAB9APOLBNPC1
SCHEMBL1208365 0.90 TGFBR1 (0.45) TGFBR1ALDH1A1RAB9APOLBNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110044938-A1 TETRAHYDROBENZOTHIOPHENE DERIVATIVES NYCOMED GMBH (DE) 2011-02-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110044938-A1 TETRAHYDROBENZOTHIOPHENE DERIVATIVES BAX, BCL2, BAD TGFBR1 1167/4885ALDH1A1 316/4885RAB9A 2531/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.